{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:21:38Z","timestamp":1787235698532,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370114"],"award-info":[{"award-number":["82370114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01827-4","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T03:12:16Z","timestamp":1754881936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A national, multicenter, retrospective study of human immunodeficiency virus infection-associated lymphoma in China"],"prefix":"10.1007","volume":"25","author":[{"given":"Chaoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zailin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"2","key":"1827_CR1","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/S2352-3018(22)00295-8","volume":"10","author":"A Rangaraj","year":"2023","unstructured":"Rangaraj A, Connor S, Harding R, et al. Advanced HIV disease and health-related suffering-exploring the unmet need of palliative care. Lancet HIV. 2023;10(2):e126\u201333.","journal-title":"Lancet HIV"},{"key":"1827_CR2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.2011.396","volume":"305","author":"MS Shiels","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Hall HI, et al. Proportions of Kaposi Sarcoma, selected non-hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980\u20132007. JAMA. 2011;305:1450\u20139.","journal-title":"JAMA"},{"key":"1827_CR3","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","volume":"7","author":"SM Kimani","year":"2020","unstructured":"Kimani SM, Painschab MS, Horner MJ, et al. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020;7:e641\u201351.","journal-title":"Lancet HIV"},{"issue":"5","key":"1827_CR4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.cco.0000432525.70099.a4","volume":"25","author":"E Cesarman","year":"2013","unstructured":"Cesarman E. Pathology of lymphoma in HIV. Curr Opin Oncol. 2013;25(5):487.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"1827_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"D Wu","year":"2019","unstructured":"Wu D, Chen C, Zhang M, et al. The clinical features and prognosis of 100 AIDS-related lymphoma cases. Sci Rep. 2019;9(1):1\u20137.","journal-title":"Sci Rep"},{"issue":"1","key":"1827_CR6","first-page":"e2019004","volume":"11","author":"A Re","year":"2019","unstructured":"Re A, Cattaneo C, Rossi G. HIV and lymphoma: from epidemiology to clinical management. Mediterr J Hematol Infect Dis. 2019;11(1):e2019004.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"1827_CR7","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1093\/cid\/ciaa1016","volume":"72","author":"MJ Horner","year":"2021","unstructured":"Horner MJ, Shiels MS, Pfeiffer RM, et al. Deaths attributable to cancer in the US human immunodefificiency virus population during 2001\u20132015. Clin Infect Dis. 2021;72:e224\u201331.","journal-title":"Clin Infect Dis"},{"key":"1827_CR8","doi-asserted-by":"crossref","first-page":"798008","DOI":"10.3389\/fonc.2021.798008","volume":"11","author":"CY Wang","year":"2022","unstructured":"Wang CY, Liu J, Liu Y. Progress in the treatment of HIV-associated lymphoma when combined with the antiretroviral therapies. Front Oncol. 2022;11:798008.","journal-title":"Front Oncol"},{"issue":"22","key":"1827_CR9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS. HIV-associated cancers and related diseases. N Engl J Med. 2018;378(22):1029\u201341.","journal-title":"N Engl J Med"},{"key":"1827_CR10","doi-asserted-by":"crossref","first-page":"102370","DOI":"10.1016\/j.eclinm.2023.102370","volume":"67","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhao J, Sun P, et al. Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study. EClinicalMedicine. 2023;67:102370.","journal-title":"EClinicalMedicine"},{"issue":"15","key":"1827_CR11","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.23.02366","volume":"42","author":"JK McGee-Avila","year":"2024","unstructured":"McGee-Avila JK, Suneja G, Engels EA, et al. Cancer treatment disparities in people with HIV in the United States, 2001\u20132019. J Clin Oncol. 2024;42(15):1810\u201320.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1827_CR12","first-page":"799","volume":"110","author":"B Valcarcel","year":"2025","unstructured":"Valcarcel B, Schonfeld SJ, Shiels MS, et al. Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis. Haematologica. 2025;110(3):799\u2013803.","journal-title":"Haematologica"},{"issue":"8","key":"1827_CR13","doi-asserted-by":"crossref","first-page":"e2224897","DOI":"10.1001\/jamanetworkopen.2022.24897","volume":"5","author":"B Park","year":"2022","unstructured":"Park B, Ahn KH, Choi Y, et al. Cancer incidence among adults with HIV in a population-based cohort in Korea. JAMA Netw Open. 2022;5(8):e2224897.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1827_CR14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/QAD.0000000000003904","volume":"38","author":"Y Jang","year":"2024","unstructured":"Jang Y, Kim T, Choi Y, et al. Association between obesity and cancer risk in adults with HIV in Korea. AIDS. 2024;38(9):1386\u201394.","journal-title":"AIDS"},{"issue":"7","key":"1827_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","volume":"163","author":"MJ Silverberg","year":"2015","unstructured":"Silverberg MJ, Lau B, Achenbach CJ, et al. North American AIDS cohort collaboration on research and design of the international epidemiologic databases to evaluate AIDS. Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med. 2015;163(7):507\u201318.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1827_CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Polesel J, Rickenbach M, et al. Swiss HIV Cohort. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425\u201332.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1827_CR17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/L16-0091","volume":"165","author":"N Lohse","year":"2016","unstructured":"Lohse N, Obel N. Update of survival for persons with HIV infection in Denmark. Ann Intern Med. 2016;165(10):749\u201350.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1827_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","volume":"19","author":"M Bower","year":"2006","unstructured":"Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006;19(1):14\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"1827_CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/QAI.0b013e31817aebfe","volume":"48","author":"G D\u2019Souza","year":"2008","unstructured":"D\u2019Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defific Syndr. 2008;48(4):491\u20139.","journal-title":"J Acquir Immune Defific Syndr"},{"issue":"10","key":"1827_CR20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","volume":"148","author":"P Patel","year":"2008","unstructured":"Patel P, Hanson DL, Sullivan PS, et al. Adult and adolescent spectrum of isease project and HIV outpatient study investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003. Ann Intern Med. 2008;148(10):728\u201336.","journal-title":"Ann Intern Med"},{"issue":"17","key":"1827_CR21","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","volume":"18","author":"M Puoti","year":"2004","unstructured":"Puoti M, Bruno R, Soriano V, et al. HIV HCC Cooperative Italian-Spanish roup. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18(17):2285\u201393.","journal-title":"AIDS"},{"issue":"23","key":"1827_CR22","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1002\/cncr.25530","volume":"116","author":"EC Seaberg","year":"2010","unstructured":"Seaberg EC, Wiley D, Mart\u00b4\u0131nez-Maza O, et al. Multicenter AIDS Cohort Study (MACS). Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer. 2010;116(23):5507\u201316.","journal-title":"Cancer"},{"issue":"12","key":"1827_CR23","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/S2352-3018(23)00238-2","volume":"10","author":"KH Mayer","year":"2023","unstructured":"Mayer KH, Allan-Blitz LT. Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions. Lancet HIV. 2023;10(12):e816\u201324.","journal-title":"Lancet HIV"},{"key":"1827_CR24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3851\/IMP1462","volume":"14","author":"J Bohlius","year":"2009","unstructured":"Bohlius J, Schmidlin K, Costagliola D, et al. Incidence and risk factors of HIV-related non-Hodgkin\u2019s lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther. 2009;14:1065.","journal-title":"Antivir Ther"},{"issue":"5","key":"1827_CR25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","volume":"117","author":"EP Simard","year":"2011","unstructured":"Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodefificiency syndrome in the United States. Cancer. 2011;117(5):1089\u201396.","journal-title":"Cancer"},{"key":"1827_CR26","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, et al. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4:e495\u2013504.","journal-title":"Lancet HIV"},{"issue":"1","key":"1827_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","volume":"17","author":"W Cao","year":"2020","unstructured":"Cao W, Hsieh E, LiT S. Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges. Curr HIV\/AIDS Rep. 2020;17(1):26\u201334.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1827_CR28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0889-8588(03)00041-8","volume":"17","author":"AE Gates","year":"2003","unstructured":"Gates AE, Kaplan LD. Biology and management of AIDS-associated nonhodgkin\u2019s lymphoma. Hematol Oncol Clin North Am. 2003;17:821\u201341.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1827_CR29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","volume":"336","author":"LD Kaplan","year":"1997","unstructured":"Kaplan LD, Straus DJ, Testa MA. Low-dose vs standard dose m-BACOD chemotherapy for non-hodgkin\u2019s lymphoma associated with human immunodefififificiency virus infection. N Engl J Med. 1997;336:1641\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"1827_CR30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1871529X20666200415121009","volume":"20","author":"R Castelli","year":"2020","unstructured":"Castelli R, Schiavon R, Preti C, Ferraris L. HIV-related lymphoproliferative diseases in the era of combination antiretroviral therapy. Cardiovasc Hematol Disord Drug Targets. 2020;20(3):175\u201380.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"1827_CR31","doi-asserted-by":"crossref","first-page":"1153790","DOI":"10.3389\/fimmu.2023.1153790","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Wu Y, et al. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: the Central and Western China AIDS lymphoma league 001 study (CALL-001 study). Front Immunol. 2023;14:1153790.","journal-title":"Front Immunol"},{"issue":"5","key":"1827_CR32","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/jcm11051447","volume":"11","author":"GN Pongas","year":"2022","unstructured":"Pongas GN, Ramos JC. HIV-associated lymphomas: progress and new challenges. J Clin Med. 2022;11(5):1447.","journal-title":"J Clin Med"},{"key":"1827_CR33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundschuh","year":"2006","unstructured":"Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera international trial (MInT) group. Lancet Oncol. 2006;7:379\u201391.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1827_CR34","first-page":"1491","volume":"22","author":"JA Sparano","year":"2004","unstructured":"Sparano JA, Lee S, Chen MG, et al. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non Hodgkin\u2019s lymphoma: an eastern cooperative oncology group trial (E1494). Clin Oncol. 2004;22(8):1491\u2013500.","journal-title":"Clin Oncol"},{"issue":"2","key":"1827_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2015-01-623900","volume":"126","author":"A Noy","year":"2015","unstructured":"Noy A, Lee JY, Cesarman E, et al. AIDS Malignancy Consortium. AMC 048: modifified CODOX-M\/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015;126(2):160\u20136.","journal-title":"Blood"},{"issue":"20","key":"1827_CR36","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","volume":"369","author":"K Dunleavy","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Shovlin M, et al. Low-intensity therapy in adults with Burkitt\u2019s lymphoma. N Engl J Med. 2013;369(20):1915\u201325.","journal-title":"N Engl J Med"},{"key":"1827_CR37","first-page":"191","volume":"92","author":"B Xicoy","year":"2007","unstructured":"Xicoy B, Ribera JM, Miralles P, et al. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage. Human Immunodefific Virus-Relat Hodgkin\u2019s Lymphoma Haematol. 2007;92:191\u20138.","journal-title":"Human Immunodefific Virus-Relat Hodgkin\u2019s Lymphoma Haematol"},{"key":"1827_CR38","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/QAD.0000000000001487","volume":"31","author":"M Sorigu\u00e9","year":"2017","unstructured":"Sorigu\u00e9 M, Garc\u00eda O, Tapia G, et al. HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma. AIDS. 2017;31:1445\u20139.","journal-title":"AIDS"},{"key":"1827_CR39","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","volume":"30","author":"S Montoto","year":"2012","unstructured":"Montoto S, Shaw K, Okosun J, et al. HIV status does not inflfluence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30:4111\u20136.","journal-title":"J Clin Oncol"},{"key":"1827_CR40","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","volume":"100","author":"M Spina","year":"2002","unstructured":"Spina M, Gabarre J, Rossi G, et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood. 2002;100:1984\u20138.","journal-title":"Blood"},{"key":"1827_CR41","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdg408","volume":"14","author":"P Hartmann","year":"2003","unstructured":"Hartmann P, Rehwald U, Salzberger B, et al. Beacopp therapeutic regimen for patients with Hodgkin\u2019s disease and HIV infection. Ann Oncol. 2003;14:1562\u20139.","journal-title":"Ann Oncol"},{"key":"1827_CR42","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2012.41.8137","volume":"30","author":"M Hentrich","year":"2012","unstructured":"Hentrich M, Berger M, Wyen C, et al. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study. J Clin Oncol. 2012;30:4117\u201323.","journal-title":"J Clin Oncol"},{"key":"1827_CR43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cncr.29066","volume":"121","author":"JJ Castillo","year":"2015","unstructured":"Castillo JJ, Bower M, Br\u00fchlmann J, et al. Prognostic factors for advanced-stage human immunodefificiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Cancer. 2015;121:423\u201331.","journal-title":"Cancer"},{"key":"1827_CR44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/MNM.0000000000000905","volume":"39","author":"IO Lawal","year":"2018","unstructured":"Lawal IO, Ankrah AO, Popoola GO, et al. 18F-FDG-PET metabolic metrics and international prognostic score for risk assessment in HIV-infected patients with Hodgkin lymphoma. Nucl Med Commun. 2018;39:1005\u201312.","journal-title":"Nucl Med Commun"},{"key":"1827_CR45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QAD.0000000000001729","volume":"32","author":"PG Rubinstein","year":"2018","unstructured":"Rubinstein PG, Moore PC, Rudek MA, et al. AIDS Malignancy Consortium (AMC). Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma. AIDS. 2018;32:605\u201311.","journal-title":"AIDS"},{"issue":"11","key":"1827_CR46","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood.2019003959","volume":"136","author":"JC Ramos","year":"2020","unstructured":"Ramos JC, Sparano JA, Chadburn A, et al. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020;136(11):1284\u201397.","journal-title":"Blood"},{"issue":"21","key":"1827_CR47","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","volume":"21","author":"C Simonelli","year":"2003","unstructured":"Simonelli C, Spina M, Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a singleinstitution study. J Clin Oncol. 2003;21(21):3948\u201354.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01827-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:53:07Z","timestamp":1764917587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01827-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01827-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required as this manuscript doesn\u2019t include details, images or videos related to the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The studies involving human participants were reviewed and approved by the institutional review board of Chongqing University Cancer Hospital. The patient provided his written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"285"}}